Impact of iv Dexamethasone on Reversal of Rocuronium-induced Neuromuscular Block by Sugammadex
Phase 4
Withdrawn
- Conditions
- Neuromuscular Blockade
- Interventions
- Drug: Normal saline
- Registration Number
- NCT02562417
- Lead Sponsor
- Centre Hospitalier Universitaire Vaudois
- Brief Summary
Sugammadex is used as a reversal drug for rocuronium- or vecuronium-induced neuromuscular block during general anaesthesia. IV dexamethasone is injected as a prophylactic measure against postoperative nausea and vomiting. Recent animal data have shown that dexamethasone may impair the reversal effect of sugammadex. The objective of this randomised controlled trial is to confirm in the clinical practice these preliminary results.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- patients scheduled to undergo microlaryngoscopy and ear-nose-throat endoscopic procedures
Exclusion Criteria
- contraindication to dexamethasone administration
- contraindication to sugammadex administration
- contraindication to rocuronium administration
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description IV dexamethasone IV dexamethasone Patients will receive 0.1 mg/kg of dexamethasone. No IV dexamethasone Normal saline Patients will receive an equivalent volume of normal saline.
- Primary Outcome Measures
Name Time Method Mean recovery time for T4/T1 ratio > 90% after sugammadex administration surgical procedure
- Secondary Outcome Measures
Name Time Method Mean recovery time for T4/T1 ratio > 70% after sugammadex administration surgical procedure Mean recovery time for T4/T1 ratio > 80% after sugammadex administration surgical procedure
Trial Locations
- Locations (1)
Lausanne University Hospital
🇨ðŸ‡Lausanne, VAud, Switzerland